Stocks
Aerie Pharmaceuticals (AERI) Debt/EBITDA US GAAP (year values) |
||||||||
| 2017 | 2018 | 2019 | 2020 | 2021 | LTM ? | |||
| Debt/EBITDA | 0.88 | 0.89 | 0.69 | 0.21 | -17.8 | -129.3 | ||
| Changes by years, y/y, % | -23% | +1% | -22% | -69% | -8 444% | |||
Aerie Pharmaceuticals. Debt/EBITDA
Aerie Pharmaceuticals. Debt/EBITDA, changes, %
Aerie Pharmaceuticals (AERI) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2021Q3 | 2021Q4 | 2022Q1 | 2022Q2 | 2022Q3 | LTM ? | |||
| Debt/EBITDA | -0.90 | -20.1 | -14.4 | -69.3 | -129.3 | -129.3 | ||
| Changes by years, y/y, % | -1 456% | -9 501% | +7 078% | +14 123% | +14 193% | |||
| Changes by quarters, q/q, % | +86% | +2 122% | -28% | +381% | +87% | |||
